InnaVirVax Initiates Phase 2 Clinical Trial Evaluating VAC-3S, A Therapeutic Vaccine Used in Combination With Standard Antiretroviral Therapy in Treatment of HIV-Infection
December 2, 2013
FINAL_InnaVirVax_VAC3S_WorldAIDS DayDec2013
Blog
Shahin Gharakhanian presentation @ AIDS 2013 Vaccine Conference on behalf of the VAC-3S P1 Clinical Trial Group.
October 15, 2013
2013 AIDS Vaccine Poster P1357
NovoBioPharma and UPstart at the University of Pennsylvania to Collaborate to Commercialize Early Stage Life Science Technologies
September 12, 2013
NBP UPStart PR 09.04.2013
NovoBioPharma, Partnership of Top Life Science Experts, Launches
June 12, 2013
NOVOBIOPHARMA Launch 61013
Presentation at the Special Seminar “30 Years of HIV Science”
June 3, 2013
Organized at the Pasteur Institute, Paris, France 21-23 May 2013. 2013 VAC3S Poster no 145 Institut Pasteur Paris May
Shahin Gharakhanian talk @ the Annual Research Seminar of the French National AIDS & Hepatitis Agency [ANRS]
May 12, 2013
“Precision Medicine / Personalized Medicine & HIV Infection: Concepts and Applications ?” Paris: 25 April 2013 [www.anrs.fr]
InnaVirVax Press Release at CROI 2013
March 17, 2013
Shahin Gharakhanian statement in the latest Press Release from InnaVirVax issued during the Conference on Retroviruses, 3-6 March 2013, Atlanta GA, USA. Reference: Katlama Ch, Launay O, Ho Tsong Fang R, Bodilis H, Calin R, Autran B, Gharakhanian S, Vieillard V, J Crouzet J, Debré P. A randomized, placebo-controlled, double-blind, phase I/IIa...
Potential role of anti-3S antibodies in an HIV medical cure strategy ?
February 4, 2013
Crouzet J, Vieillard V, Debré P, Katlama C, Launay O, Ho Tsong Fang R, Desfontaines-Batéjat D, Marcu M, Gharakhanian S. Potential role of anti-3S antibodies in an HIV medical cure strategy ?. Oral/Poster Presentation. HIV Cure & Eradication Workshop, 24-25 January 2013; Milan, Italy . [Poster: distinguished as best poster of the Workshop]. We...
Course Leader for a New Seminar for Biotech and Pharma in Boston
December 16, 2012
“Launching a High-Value Medical & Scientific Affairs Team” Medical & Scientific Affairs Seminar Boston Jan 2013
InnaVirVax Press Release on World AIDS Day
December 16, 2012
InnaVirVax: the Phase I/IIa clinical study of its VAC-3S immunotherapeutic vaccine in the treatment of HIV infection has achieved its primary endpoint InnaVirVax Press Release 30NOV2012